Bio-Techne Corp
TECH
Market Cap$8.33B
Close$
$39.52
25.6% downside
Current Fair Value
25.6% downsideOvervalued by 25.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.33 Billion |
|---|---|
| Enterprise Value | $8.65 Billion |
| Dividend Yield | $0.32 (0.6021829130598421%) |
| Earnings per Share | $1.07 |
| Beta | 1.38 |
| Outstanding Shares | 157,372,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 63.51 |
|---|---|
| PEG | -117.71 |
| Price to Sales | 7.59 |
| Price to Book Ratio | 4.43 |
| Enterprise Value to Revenue | 7.16 |
| Enterprise Value to EBIT | 50.32 |
| Enterprise Value to Net Income | 65 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bio-Techne Corp
2,100 employees
CEO: Charles Kummeth Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems , No...